Some of this has been mentioned but it is good to hear it from...

Some of this has been mentioned but it is good to hear it from the CEO. In recent communication with Joel he confirmed the following:

- All 6 programs qualify for FDA fast track
- no new molecules are used in any of the 6 programs which accelerate FDA approval
- there is a news flow expected from now until the end of the year( my personal guess is that the news flow will star from July or after US listing)
- they are now working on the SEC filing, an announcement on dual listing will follow once done
- IHL received great interest from US investors through EAS and other channels as well
- all board members own shares paid for by their money, big part of the medical stuff as well ( they are all believers and work as hard and quick as they can to get things done)

I have bought more after this communication with him.

good luck to all.